GE HealthCare CEO has 6,303 shares withheld for tax

GE HealthCare’s CEO reported a routine tax-withholding share disposition tied to RSU vesting, with substantial direct holdings remaining.

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. (GEHC) reported that President and CEO Peter J. Arduini had 6,303 shares of common stock withheld on September 3, 2026 to satisfy tax withholding obligations related to the vesting of restricted stock units. After this withholding, he directly holds 241,606 shares of GEHC common stock.

Insider Trade Summary

Tax Withholding: 6,303 shares

Tax Withholding 1 txn

Insider Arduini Peter J

Role President and CEO

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock, par value $0.01 per share F1	6,303	$70.56	$445K

Holdings After Transaction: Common Stock, par value $0.01 per share — 241,606 shares (Direct)

Footnotes (1)

1. F1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Key Figures

Shares withheld for taxes: 6,303 shares Per-share value for withholding: $70.56 per share Shares held after transaction: 241,606 shares +1 more

4 metrics

Shares withheld for taxes 6,303 shares Common stock withheld on September 3, 2026 to satisfy tax withholding obligations on RSU vesting

Per-share value for withholding $70.56 per share Value used for the 6,303 GEHC shares withheld for tax obligations

Shares held after transaction 241,606 shares Direct holdings of GEHC common stock by Peter J. Arduini after the September 3, 2026 transaction

Tax-withholding transactions 1 transaction, 6,303 shares Summary of exercise-price-or-tax-liability type dispositions reported in this Form 4

Key Terms

restricted stock units, tax withholding obligations, Form 4, Rule 10b5-1

4 terms

restricted stock units financial

"in connection with the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"to satisfy tax withholding obligations in connection with the vesting"

Form 4 regulatory

"reported on this Form 4"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Rule 10b5-1 regulatory

"The filing’s Rule 10b5-1 checkbox is not marked"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

What insider transaction did GEHC’s CEO report on this Form 4?

GE HealthCare’s President and CEO Peter J. Arduini reported the withholding of 6,303 shares of common stock on September 3, 2026 to satisfy tax withholding obligations arising from the vesting of restricted stock units.

Was the GEHC insider transaction a market sale of shares?

No. The Form 4 describes a Code F transaction, representing withholding of shares to pay tax liabilities upon RSU vesting, not an open-market purchase or sale. The filing also indicates no Rule 10b5-1 trading plan was reported.

How many GEHC shares does the CEO hold after this tax-withholding event?

Following the September 3, 2026 transaction, President and CEO Peter J. Arduini directly holds 241,606 shares of GE HealthCare Technologies Inc. common stock, as reported in the Form 4.

At what price were the GEHC shares withheld for taxes in this Form 4?

The 6,303 shares of GEHC common stock withheld for tax purposes were valued at $70.56 per share, according to the reported transaction price in the Form 4 filing.

Does the GEHC Form 4 indicate use of a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is not marked, and there is no footnote stating that the transaction was made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/04/2026 - 04:40 PM Accepted by SEC EDGAR 09/04/2026 - 04:39 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Arduini Peter J

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO ILLINOIS 60661

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	09/03/2026		F		6,303(1)	D	$70.56	241,606	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	09/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)